Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 16571-862

This is the packaging information for a medication called "bupropion hydrochloride extended-release tablets". Each tablet contains 150mg of the active ingredient. The usual dosage is one tablet per day or as directed by a physician. It is important to keep this medication and all drugs out of reach of children. The medication guide must be provided separately to each patient. This package is child-resistant and should be stored at a controlled room temperature of 20-25°C. It is not recommended to use this medication in combination with medication that contains bupropion hydrochloride. The medication is manufactured by Gravity Pharmaceuticals in India and is distributed by Rising Pharma Holdings in the United States. The text also includes reference to the registered trademark Zyban, which contains bupropion hydrochloride.*

This is a medication called buPROPion Hydrochloride that comes in extended-release tablets. Each tablet contains 300mg of the active ingredient. The usual dosage is one tablet daily or as directed by a physician. It's important to read the prescribing information as this medication should not be used in combination with Zyban or any other medicines that contain bupropion hydrochloride. The package is child-resistant and should be kept out of the reach of children. The medication should be stored at 20 to 25°C and be protected from light. Zyban is a registered trademark of GlaxoSmithKiine. It was manufactured by Graviti Pharmaceuticals Put. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ. A Medication Guide is included with the tablets that should be dispensed separately to each patient by the PHARMAGIST.*